Community Outreach Boosted Enrolment for a Birth Control Study.

Community Outreach Case Study: Women’s Health Phase III

Innovative Trials were approached to support a mid size pharmaceutical company to accelerate enrolment for a Phase III birth control study in the US. The study needed to enrol 1357 healthy women aged 18-35 in a 7 month period.

Request case study

Rapid implementation of a 2-month rescue pilot led to a 113% increase in randomisation rates, getting the study back on schedule.

Rescue Case Study: Oncology Phase III

A leading biopharmaceutical company approached Innovative Trials to increase enrolment for their phase III study of Metastatic Colorectal Cancer (mCRC). The study needed to enroll 1250 eligible patients, however sites were experiencing severe enrolment fatigue and enrolment was lagging.

Request case study

Innovative Trials’ Clinical Enrolment Managers enabled sites to significantly increase enrolment in a complex pancreatic cancer study.

Phase III germline BRCA mutated (gBRCAm) metastatic pancreatic cancer

Innovative Trials were approached by the study sponsor to boost enrolment for a phase 3 study in pancreatic cancer.

The study required patients with gBRCAm metastatic pancreatic cancer whose disease had not progressed on first line platinum based chemotherapy.

Request case study

Clinical Enrolment Managers supported sites able to screen 73.2% more patients.

Paediatric Case Study: Moderate to Severe Atopic Dermatitis Phase III

The study sponsor approached Innovative Trials to support site enrolment for this phase 3 study in atopic dermatitis.

This particular study required children with moderate to severe atopic dermatitis, to trial an oral treatment, around their school schedules.

Request case study

Need support to recruit patients to your clinical trial?
Contact us to find out how we can help you.

Contact

Therapy Areas

We have extensive experience of study phases Ib to IV, adults and paediatrics and both acute and chronic conditions.

Contact
  • Intra abdominal pain
  • Post operative pain
  • Non Alcoholic Fatty Liver Disease (NAFLD)
  • Non Alcoholic steatohepatitis (NASH)
  • Hypercholesterolaemia
  • Type II Diabetes
  • Anaemia
  • Haemophilia
  • Sickle Cell
  • Thrombocytopenia
  • Osteoarthritis
  • Atopic Dermatitis
  • Hidradenitis Suppurativa
  • Psoriasis
  • Crohn’s Disease
  • Ulcerative Colitis
  • Bacterial infection – Sepsis
  • C-Diff
  • Intra-abdominal infectious disease
  • Pneumonia
  • Ankylosing Spondylitis
  • Alopecia
  • Asthma
  • Atopic Dermatitis
  • Crohn’s Disease
  • Hidradenitis Suppurativa
  • Lupus
  • Nasal Polyps
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Ulcerative Colitis
  • Vitiligo
  • Alzheimer’s Disease
  • Epilepsy
  • Depression
  • Duchenne Muscular Dystrophy (DMD)
  • Dyskinesia in Cerebral Palsy
  • Migraine
  • Multiple Sclerosis
  • Parkinson’s Disease
  • Schizophrenia
  • Acute Myeloid Leukaemia
  • Basal cell carcinoma
  • Bladder Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Head & Neck Cancer
  • Liver cancer
  • Lung Cancer
  • Lymphoma
  • Metastatic bone pain
  • Myelofibrosis
  • Mutant Tumours
  • NSCLC
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Solid Tumour
  • Treatment Resistance post cancer treatment
  • Urothelial Cancer
  • Asthma
  • COPD
  • Over-active bladder
  • Pneumonia
  • Urinary Tract Infection
  • Birth control
  • Interstitial cystitis
  • STD Prevention
  • Urinary Tract Infection